Aurinia Pharmaceuticals Inc. buy BiotechBee
Start price
04.01.23
/
60%
€6.46
Target price
31.12.25
€12.00
Performance (%)
63.49%
End price
05.05.23
€10.56
Summary
This prediction ended on 05.05.23 with a price of €10.56. With a performance of 63.49% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 0.961% | 0.961% | 109.509% | 34.185% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % | 48,88 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % | 83,74 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % | 60,39 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % | 61,27 % |
According to BiotechBee what are the pros and cons of Aurinia Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year